High dose and hepatobiliary dysfunction are associated with hand-foot syndrome in patients with lymphoma using pegylated liposomal doxorubicin: a retrospective study

• Main Authors: Yanfang Zhao (Author), Wenjia Su (Author), Guohua Liang (Author), Xiaoyu Shan (Author), Weiwei Ma (Author), Dabei Tang (Author), Liru Li (Author), Xingjian Niu (Author), Shu Zhao (Author), Qingyuan Zhang (Author), Wenhui Zhao (Author)
• Format: Book
• Published: BMC, 2021-10-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Purpose In clinical practice, the risk factors for pegylated liposomal doxorubicin-related hand-foot syndrome remain unclear. The purpose of this study was to determine the risk factors associated with hand-foot syndrome in patients with lymphoma using pegylated liposomal doxorubicin. Metho...